Cargando…

(18)F-RGD PET/CT imaging reveals characteristics of angiogenesis in non-small cell lung cancer

BACKGROUND: The objective of this study was to explore the benefit of (18)F-AlF-NOTA-PRGD2 positron emission tomography/computed tomography (denoted as (18)F-RGD PET/CT) imaging for determining the clinical pathologic features of non-small cell lung cancer (NSCLC). METHODS: Seventy-two patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Li, Zhao, Wei, Sun, Xiaorong, Liu, Ning, Zhou, Yue, Luan, Xiaohui, Gao, Song, Zhao, Shuqiang, Yu, Jinming, Yuan, Shuanghu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481644/ https://www.ncbi.nlm.nih.gov/pubmed/32953507 http://dx.doi.org/10.21037/tlcr-20-187

Ejemplares similares

Potential (18)F-RGD PET/CT and DCE-MRI Imaging-Based Biomarkers for Postoperative Survival Prediction Among Patients With Newly Diagnosed Glioblastoma Treated With Bevacizumab and Chemoradiotherapy
por: Li, Li, et al.
Publicado: (2022)

Tumor angiogenesis at baseline identified by (18)F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
por: Wei, Yuchun, et al.
Publicado: (2022)

A Comparative Study of Noninvasive Hypoxia Imaging with (18)F-Fluoroerythronitroimidazole and (18)F-Fluoromisonidazole PET/CT in Patients with Lung Cancer
por: Wei, Yuchun, et al.
Publicado: (2016)

(18)F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer
por: Luan, Xiaohui, et al.
Publicado: (2016)

A Pilot Study of (18)F-Alfatide PET/CT Imaging for Detecting Lymph Node Metastases in Patients with Non-Small Cell Lung Cancer
por: Zhou, Yue, et al.
Publicado: (2017)

Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors
por: Li, Li, et al.
Publicado: (2022)

Diagnostic and Predictive Value of Using RGD PET/CT in Patients with Cancer: A Systematic Review and Meta-Analysis
por: Liu, Jie, et al.
Publicado: (2019)

[(18)F]AlF-NOTA-FAPI-04 PET/CT uptake in metastatic lesions on PET/CT imaging might distinguish different pathological types of lung cancer
por: Wei, Yuchun, et al.
Publicado: (2021)

(18)F-RGD PET/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment
por: Liu, Jie, et al.
Publicado: (2021)

Head and neck tumors angiogenesis imaging with (68)Ga-NODAGA-RGD in comparison to (18)F-FDG PET/CT: a pilot study
por: Durante, Steve, et al.
Publicado: (2020)

Angiogenesis imaging study using interim [(18)F] RGD-K5 PET/CT in patients with lymphoma undergoing chemotherapy: preliminary evidence
por: Tonnelet, David, et al.
Publicado: (2021)

Fluorine-18 labeled amino acids for tumor PET/CT imaging
por: Qi, Yiqiang, et al.
Publicado: (2017)

Prognostic Value of (18)F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis
por: Liu, Jing, et al.
Publicado: (2016)

Meta-analysis of (18) F-PSMA-1007 PET/CT, (18) F-FDG PET/CT, and (68)Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
por: Yu, Wenxiao, et al.
Publicado: (2023)

Negative Correlation Between (18)F-RGD Uptake via PET and Tumoral PD-L1 Expression in Non-Small Cell Lung Cancer
por: Wu, Leilei, et al.
Publicado: (2022)

Hypoxia with (18)F-fluoroerythronitroimidazole integrated positron emission tomography and computed tomography ((18)F-FETNIM PET/CT) in locoregionally advanced head and neck cancer: Hypoxia changes during chemoradiotherapy and impact on clinical outcome
por: Hu, Man, et al.
Publicado: (2019)

Stereotactic Comparison Study of (18)F-Alfatide and (18)F-FDG PET Imaging in an LLC Tumor-Bearing C57BL/6 Mouse Model
por: Wei, Yu-Chun, et al.
Publicado: (2016)

Use of 18F-FDG-PET/CT for Retroperitoneal/Intra-Abdominal Soft Tissue Sarcomas
por: Liu, Dao-ning, et al.
Publicado: (2018)

Evaluation of a dimeric-cRGD peptide for targeted PET-CT imaging of peripheral angiogenesis in diabetic mice
por: Hedhli, Jamila, et al.
Publicado: (2018)

Comparison of (18)F-NaF PET/CT and (18)F-FDG PET/CT for Detection of Skull-Base Invasion and Osseous Metastases in Nasopharyngeal Carcinoma
por: Zhang, Yin, et al.
Publicado: (2018)

Comparison and evaluation of two RGD peptides labelled with (68)Ga or (18)F for PET imaging of angiogenesis in animal models of human glioblastoma or lung carcinoma
por: Provost, Claire, et al.
Publicado: (2018)

Differential diagnostic value of (18)F-FDG PET/CT in osteolytic lesions
por: Li, Xiaomeng, et al.
Publicado: (2020)

Can (18)F-PSMA-7Q PET/CT replace prostate biopsy for the diagnosis of prostate cancer?—A single-center retrospective study
por: Liu, Yachao, et al.
Publicado: (2023)

Comparison of integrin α(v)β(3) expression with (68)Ga-NODAGA-RGD PET/CT and glucose metabolism with (18)F-FDG PET/CT in esophageal or gastroesophageal junction cancers
por: Dietz, Matthieu, et al.
Publicado: (2023)

Noninvasive Evaluation of Metabolic Tumor Volume in Lewis Lung Carcinoma Tumor-Bearing C57BL/6 Mice with Micro-PET and the Radiotracers (18)F-Alfatide and (18)F-FDG: A Comparative Analysis
por: Wei, Yu-Chun, et al.
Publicado: (2015)

Biological characteristics of (18)F-FDG PET/CT imaging of cerebral alveolar echinococcosis
por: Yibulayin, Amina, et al.
Publicado: (2018)

Imaging angiogenesis in atherosclerosis in large arteries with (68)Ga-NODAGA-RGD PET/CT: relationship with clinical atherosclerotic cardiovascular disease
por: Dietz, Matthieu, et al.
Publicado: (2021)

[18F]FDG PET/CT versus [18F]FDG PET/MRI for the diagnosis of colorectal liver metastasis: A systematic review and meta-analysis
por: Miao, Zhi, et al.
Publicado: (2023)

Complementary findings on (18)F-FDG PET/CT and (18)F-NaF PET/CT in a patient with Erdheim-Chester disease
por: Sabino, Daniela, et al.
Publicado: (2017)

Diagnostic Value of (18)F-NOTA-FAPI PET/CT in a Rat Model of Radiation-Induced Lung Damage
por: Qin, Xueting, et al.
Publicado: (2022)

The role of (18)F-FDG PET/CT imaging in patient with malignant PEComa treated with mTOR inhibitor
por: Sun, Lu, et al.
Publicado: (2015)

Recurrence patterns are significantly associated with the (18)F‑FDG PET/CT radiomic features of patients with locally advanced non‑small cell lung cancer treated with chemoradiotherapy
por: Liu, Wenju, et al.
Publicado: (2023)

(18)F-Fluorothymidine PET-CT for Resected Malignant Gliomas before Radiotherapy: Tumor Extent according to Proliferative Activity Compared with MRI
por: Zhao, Fen, et al.
Publicado: (2015)

Comparison of (18)F-FDG PET/CT imaging with different dual time (18)F-FDG PET/CT with forced diuresis in clinical diagnosis of prostate cancer
por: Yu, Longhua, et al.
Publicado: (2023)

PET imaging of (68)Ga-NODAGA-RGD, as compared with (18)F-fluorodeoxyglucose, in experimental rodent models of engrafted glioblastoma
por: Isal, Sibel, et al.
Publicado: (2018)

Receiver operating characteristic (ROC) curve for classification of (18)F-NaF uptake on PET/CT
por: Valadares, Agnes Araujo, et al.
Publicado: (2016)

Comparison of primary target volumes delineated on four-dimensional CT and (18) F-FDG PET/CT of non-small-cell lung cancer
por: Duan, Yi-Li, et al.
Publicado: (2014)

Metabolic Characteristics and Diagnostic Contribution of (18)F-FDG PET/CT in Gastric Carcinomas
por: Arslan, Esra, et al.
Publicado: (2020)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Active inflammation in (18)F-methylcholine PET/CT
por: Le, Chau, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ddn2otn1u09pirkvs4ncj7mvv8